Agilent Stock Gains as Earnings Surprise Despite Research Funding Cuts -- Barrons.com

Dow Jones
05-29

By Josh Nathan-Kazis

Shares of Agilent Technologies were climbing late Wednesday after the lab tools and testing company reported better financial results than expected for the second quarter of its fiscal year.

Agilent's peers have been buffeted by the Trump administration's disruptions to funding for U.S. academic labs. Those labs are an important customer for the companies that make high-end instruments used in scientific research.

On an investor call late Wednesday, however, Agilent CEO Padraig McDonnell said that the company hadn't been significantly affected.

"Academia and government declined only 2% in the quarter, better than expected performance in the U.S. and globally," McDonnell said. "Given that we were ahead of others talking about potential U.S. funding impacts in our first quarter earnings call, and did better than expected in Q2, we feel we already have adequately captured any variability looking forward."

The stock was up 6% after hours.

McDonnell also said the company believes it can mitigate "most of the impact" of the new U.S. tariff regime in its 2025 fiscal year, and can "fully mitigate" the effects in 2026, by diversifying the company's supply chain, implementing "strategic pricing," and other measures.

Agilent's revenue was were $1.7 billion in the second quarter, up 6% on a reported basis, while the consensus forecast among analysts tracked by FactSet was for $1.6 billion. Non-GAAP earnings were $1.31 a share, better than the consensus call of $1.26.

The company raised its forecast of full-year revenue to between $6.73 billion and $6.81 billion, from a prior call of between $6.68 billion and $6.76 billion. Analysts were expecting sales of $6.73 billion.

Management maintained an earlier forecast that non-GAAP earnings per share will be between $5.54 and $5.61.

Write to Josh Nathan-Kazis at josh.nathan-kazis@barrons.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

May 28, 2025 17:32 ET (21:32 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10